BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1718672)

  • 1. Washless double staining of unfixed nuclei for flow cytometric analysis of DNA and a nuclear antigen (Ki-67 or bromodeoxyuridine).
    Larsen JK; Christensen IJ; Christiansen J; Mortensen BT
    Cytometry; 1991; 12(5):429-37. PubMed ID: 1718672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of proliferation associated nuclear antigens using washless staining of unfixed cells.
    Landberg G; Roos G
    Cytometry; 1992; 13(3):230-40. PubMed ID: 1374305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Washless" procedures for nuclear antigen detection.
    Larsen JK
    Methods Cell Biol; 1994; 41():377-88. PubMed ID: 7532266
    [No Abstract]   [Full Text] [Related]  

  • 4. Washless double staining of a nuclear antigen (Ki-67 or bromodeoxyuridine) and DNA in unfixed nuclei.
    Larsen JK
    Methods Cell Biol; 1990; 33():227-34. PubMed ID: 1707485
    [No Abstract]   [Full Text] [Related]  

  • 5. [A simple method for flow cytometric measurement of Ki-67 reactive antigen on small solid tissues].
    Murakami T; Oga A; Uchiyama T; Kimura Y; Morimoto H; Suzuki T; Takahashi M
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):737-40. PubMed ID: 7683864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of cell cycle-related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique.
    Endl E; Steinbach P; Knüchel R; Hofstädter F
    Cytometry; 1997 Nov; 29(3):233-41. PubMed ID: 9389440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA.
    Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M
    Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination of bromodeoxyuridine labelled and unlabelled mitotic cells in flow cytometric bromodeoxyuridine/DNA analysis.
    Jensen PO; Larsen JK; Christensen IJ; van Erp PE
    Cytometry; 1994 Feb; 15(2):154-61. PubMed ID: 8168402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of flow-cytometric determination of Ki67 expression as a measure of growth factor response in acute myelogenous leukemia.
    Gore SD; Weng LJ; Burke PJ
    Exp Hematol; 1993 Dec; 21(13):1702-8. PubMed ID: 7694870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow cytometric analysis of Ki-67 reactive antigen].
    Murakami T; Sasaki K; Takahashi M
    Nihon Rinsho; 1992 Oct; 50(10):2355-9. PubMed ID: 1280305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of the expression of PCNA during the cell cycle in HeLa cells and effects of the inhibition of DNA synthesis on it.
    Sasaki K; Kurose A; Ishida Y
    Cytometry; 1993 Nov; 14(8):876-82. PubMed ID: 7904555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-phase arrest of nutrient deprived lung cancer cells.
    Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
    Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric cell-cycle analysis of peripheral blood-activated lymphocyte subsets using staining based on the TdT method for incorporated BrdUrd.
    Dolbeare F; Lopez N; Lopez A; Amigo ML; Ciudad J; Del Cañizo MC; San Miguel JF; Orfao A
    Cytometry; 1996 Dec; 25(4):317-23. PubMed ID: 8946138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved staining method for the simultaneous flow cytofluorometric analysis of DNA content, S-phase fraction, and surface phenotype using single laser instrumentation.
    Toba K; Winton EF; Bray RA
    Cytometry; 1992; 13(1):60-7. PubMed ID: 1372203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subdivision of S-phase by analysis of nuclear 5-bromodeoxyuridine staining patterns.
    van Dierendonck JH; Keyzer R; van de Velde CJ; Cornelisse CJ
    Cytometry; 1989 Mar; 10(2):143-50. PubMed ID: 2469556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.
    Swanson SA; Brooks JJ
    Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry.
    Schutte B; Reynders MM; van Assche CL; Hupperets PS; Bosman FT; Blijham GH
    Cytometry; 1987 Jul; 8(4):372-6. PubMed ID: 3113895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment.
    Takagi S; McFadden ML; Humphreys RE; Woda BA; Sairenji T
    Cytometry; 1993; 14(6):640-8. PubMed ID: 8404370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
    Pollack A; Terry NH; Wu CS; Wise BM; White RA; Meistrich ML
    Cytometry; 1995 May; 20(1):53-61. PubMed ID: 7541331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content.
    Schutte B; Tinnemans MM; Pijpers GF; Lenders MH; Ramaekers FC
    Cytometry; 1995 Oct; 21(2):177-86. PubMed ID: 8582238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.